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The Drosophila cyclin E (DmcycE) gene gives rise to two transcripts encoding proteins that differ at their N termini,
DmcycEII and DmcycEI. This study presents the first in vivo dissection of Cyclin E function. Ectopic expression studies
using N- and C-terminal deletions of DmcycEI revealed that a region of 322 residues surrounding the cyclin box is sufficient
to induce entry of G1-arrested larval eye imaginal disc cells into S phase. Ectopic expression of DmcycEI in the eye disc has
been previously shown to drive anterior, but not posterior, G1-phase cells within the morphogenetic furrow (MF) into S
phase. Significantly, ectopic expression of DmcycEII and N-terminal deletions of DmcycEI were able to drive all G1 cells
within the morphogenetic furrow into S phase, while a C-terminal deletion of DmcycEI could not. The p21 homolog Dacapo
was shown by yeast two-hybrid, coimmunolocalization, and in vivo functional studies not to be the mediator of the
DmcycEI inhibition in posterior part of the MF. Taken together, these results reveal a novel zone within the posterior region
of the MF where DmcycEI but not DmcycEII function is inhibited, and suggest that DmcycEII is a more potent inducer of
S phase. © 2001 Elsevier Science
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The G1 to S phase transition is a critical point in the cell
cycle where the cell responds to external cues, such as
growth factors, before committing to enter a round of cell
division or to undergo differentiation (reviewed by Zhu and
Skoultchi, 2001; Prober and Edgar, 2001). In multicellular
animals, the G1 to S phase transition is regulated by G1
cyclins, Cyclin D and Cyclin E, which bind to and activate
Cdk4(6) and Cdk2 protein kinases, respectively (reviewed
by Ekholm and Reed, 2000). Cyclin/Cdk activity is regu-
lated by phosphorylation of the Cdk subunit and by asso-
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All rights reserved.ciation with Cdk inhibitory proteins (Ckis; reviewed by
Lew and Kornbluth, 1996; Sherr and Roberts, 1995). Ckis
are of two classes: the p21 class (p21, p27, and p57) that bind
to and inhibits all G1 cyclin-Cdks and the p16 class that
specifically targets Cyclin D/Cdk4(6).
Overexpression of either Cyclin E or D shortens G1 phase
and decreases the requirement for growth factors for the G1
to S phase transition (reviewed by Ekholm and Reed, 2000).
Conversely, ablation studies have shown that Cyclin D is
required in mid-G1 phase, while Cyclin E is required at the
G1/S boundary. Thus, Cyclin D and Cyclin E are essential
and rate-limiting for the G1 to S phase transition. Although
Cyclin D functions upstream of Cyclin E, expression of
cyclin E under control of the cyclin D1 promoter in
knock-in mice rescues a cyclin D1 deficiency (Geng et al.,
1999), suggesting that Cyclin E can perform all of the
essential functions of Cyclin D1. The only critical target of
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© 2001 Elsevier Science. ACyclin D/Cdk4(6) appears to be the Retinoblastoma (Rb)
tumor suppressor protein (reviewed by Ekholm and Reed,
2000). In its unphosphorylated form, Rb binds to the
E2F/DP transcription factor forming an inactive complex at
S phase gene promoters (reviewed by Dyson, 1998). Phos-
phorylation of Rb by Cyclin D/Cdk4(6) and Cyclin E/Cdk2
inactivates Rb and allows S phase gene transcription; how-
ever, Cyclin E/Cdk2 has other important roles in the G1 to
S phase transition, independent of Rb. Nuclear accumula-
tion of Cyclin E/Cdk2 has also been shown to be important
in the concentration-dependent destruction of the p27 Cdk
inhibitor (Swanson et al., 2000). Recently, Cyclin E/Cdk2
has been shown to have a direct role in the initiation of
DNA replication that depends upon its recruitment to
replication origins by the prereplication complex protein
Cdc6 (Furstenthal et al., 2001). Furthermore, roles for
Cyclin E/Cdk2 in transcriptional regulation of histone
genes and as a coactivator with the androgen receptor have
been revealed (Ma et al., 2000; Zhao et al., 2000; Yamamoto
et al., 2000). Cyclin E/Cdk2 also plays an important role in
centrosome duplication (Hinchcliffe et al., 1999; Matsu-
moto et al., 1999; Okuda et al., 2000; Tokuyama et al.,
2001). Thus, Cyclin E/Cdk2 functions in multiple pathways
in the G1 to S phase transition.
Although regulation of the G1 to S phase transition has
been well studied in mammalian tissue culture cells, rela-
tively few studies have addressed G1-S phase regulation in a
whole animal. Drosophila melanogaster provides an excel-
lent animal model system to study regulation of the cell
cycle during development, since the pattern of cell divi-
sions during development is well characterized and ho-
mologs of many mammalian cell cycle regulators are
present (reviewed by Vidwans and Su, 2001). In Drosophila,
Cyclin E appears to be the most important cyclin in the G1
telophase; and I, interphase. (E) An embryo undergoing the G2-
regulated cycle 14 (;3.5 h AED) showing an apparent decrease in
DmcycE protein abundance in mitotic domains. (F) The same
embryo as in (E) costained with Hoechst 33258 showing mitotic
nuclei. Note in (B), (D), and (F), nuclear DmcycE staining has
quenched the Hoechst 33258 staining. (G) An embryo after the
completion of cycle 16 (;6–7 h AED) showing DmcycE in the
epidermis of the thoracic segments T1 and T2 that undergo a 17th
cycle (arrowheads). Expression in the underlying peripheral ner-
vous system (PNS) and central nervous system (CNS) can also be
seen. (H) An embryo a short time later (;7 h AED) showing
DmcycE in PNS cells. (I) A germ band-retracted embryo (;10 h
AED) showing DmcycE in the PNS and CNS. (J) An embryo at the
same stage as (I) showing DmcycE in the pole (germ) cells (pc) and
in the endo-replicating tissue of the midgut (mg). (K) A ventral view
of an embryo at ;13 h AED showing DmcycE in the CNS. (L) An
embryo at the end of head involution (;16 h AED) showing
expression of DmcycE in the CNS and regions in the endo-
replicating tissues of the midgut (mg). Embryos are orientated
anterior to the left and ventral side down in this and subsequentFIG. 1. DmcycE protein distribution during embryogenesis. Em-
bryos were incubated with DmcycE mouse polyclonal antisera
followed by HRP detection (dark blue). (A) A syncytial embryo in
interphase (;1 h AED) showing nuclear localization of DmcycE. (B)
An embryo undergoing the parasynchronous syncytial divisions
(;1 h AED) costained with Hoechst 33258 (bright blue), showing
nuclear localization of DmcycE in interphase nuclei and loss from
the nuclei as they enter prophase. (C) An embryo undergoing the
parasynchronous syncytial divisions (;1 h AED). (D) The same
embryo as in (C) costained with Hoechst 33258 showing reaccu-
mulation of DmcycE in telophase nuclei. In (B) and (D), the stagesunless otherwise indicated.
ll rights reserved.
Lanes 1 and 4, protein extract from heat shocked control larvae.
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© 2001 Elsevier Science. Ato S phase transition, since recent studies have shown that
Cyclin D/Cdk4(6) acts primarily as a cell growth regulator
(Datar et al., 2000; Meyer et al., 2000). As in mammalian
cells, Drosophila cyclin E (DmcycE) is essential and rate
limiting for the G1 to S phase transition (Knoblich et al.,
1994; Richardson et al., 1995; Secombe et al., 1998). Dm-
cycE encodes two proteins with common C-terminal and
unique N-terminal regions that arise from alternative tran-
scripts and are differentially expressed during development
(Richardson et al., 1993). DmcycEII mRNA is supplied
maternally and is present during the first 13 rapid synchro-
nous divisions, whereas DmcycEI mRNA is zygotically
expressed in all proliferating tissues during embryogenesis
and is down-regulated when cells exit into G1 phase (Rich-
ardson et al., 1995).
This study concerns the investigation of the properties of
DmcycEI and II proteins. The DmcycEII transcript encodes
a 709-amino acid protein with a unique 119-amino acid
N-terminal region, while the DmcycEI protein has 12
unique amino acids at the N terminus (Richardson et al.,
1993). The cyclin box, a conserved region of approximately
100 amino acids required for binding to the Cdk subunit
(Lees and Harlow, 1993; Jeffrey et al., 1995), is located in the
central region of DmcycE proteins. At the N and C termini,
both proteins contain several PEST sequences, which are
sequences rich in proline, glutamic acid, aspartic acid,
serine, and threonine flanked by basic amino acids that are
present in many unstable proteins (Rogers et al., 1986). A
conserved sequence LTPP in the C terminus of human
Cyclin E has been shown to be required for the ubiquitin-
mediated degradation of the protein (Won and Reed, 1996;
Clurman et al., 1996) and is also present in Drosophila
Cyclin E. The presence of PEST sequences and the LTPP
destruction sequence in DmcycE suggests that the targeted
destruction of DmcycE may also occur in Drosophila.
The unique N termini of DmcycEI and II may confer
Lanes 2 and 5, protein extract from heat shocked hsp70-DmcycEI
larvae. Lanes 3 and 6, protein extract from heat-shocked hsp70-
DmcycEII larvae taken immediately after heat shock. Lanes 1–3 were
detected by using the rat anti-DmcycEII polyclonal antisera. A
DmcycEII-specific band is observed in lane 3, and is absent from lanes
1 and 2. Lanes 4–6 were detected by using the mouse DmcycE
monoclonal antisera, which detects DmcycEI and DmcycEII. The
bands corresponding to DmcycEI protein (lane 5, lower arrow) are
distinguishable from the higher molecular weight bands of the Dm-
cycEII protein (lane 6, higher arrow). (B–F) Embryos were stained with
DmcycEII rat polyclonal antisera and detected via HRP staining. (B) A
syncytial embryo (;1 h AED) showing nuclear localization of Dmcy-
cEII. (C) Cellularized embryo at G2 of cycle 14 (;3.5 h AED), showing
nuclear localization of DmcycEII. (D) An embryo undergoing cycle 15
(;5 h AED) showing generally weak expression of DmcycEII, but
higher levels in the amnioserosa (am). (E) A germ band-retracted
embryo (;10 h AED). (F) A ventro-lateral view of an embryo under-
going head involution (;13 h AED). Note in (E) and (F) that staining isFIG. 2. Distribution of DmcycEII during development. (A) West-
ern analysis of Drosophila DmcycE proteins using rat polyclonal
antiserum raised to the unique region of DmcycEII protein and
mouse monoclonal antibody raised to full-length DmcycEI (8B10).only detectible in the pole (germ) cells (pc).
ll rights reserved.
160 Crack et al.unique properties on each protein. The 119-residue unique
N terminus of DmcycEII has many putative phosphoryla-
tion sites, as well as additional PEST sequences. DmcycEI
and II proteins also contain different putative nuclear local-
ization signals (NLS). The potential NLS of DmcycEII is
similar to the canonical SV40 T antigen NLS, whereas
DmcycEI has a putative bipartite NLS (Richardson et al.,
1993). DmcycEII but not DmcycEI has multiple serine and
threonine residues flanking the potential NLS (Richardson
et al., 1993), raising the possibility that phosphorylation of
these residues may affect nuclear localization (Garcia-
Bustos et al., 1991).
To assess whether DmcycEI and II have different proper-
ties, we have investigated the distribution of DmcycEI and
II proteins during development and have ectopically ex-
pressed DmcycE constructs in the eye imaginal disc to
examine the functional domains of DmcycE proteins.
These studies have revealed the presence of an inhibitory
zone within the morphogenetic furrow of the eye disc that
inhibits the function of DmcycEI. In contrast, DmcycEII
and N terminal deletions of DmcycEI are refractory to this
inhibition, suggesting that the inhibition is mediated
through the N terminus of DmcycEI. We provide evidence
that the inhibition of DmcycEI is not mediated by Dacapo,
the Drosophila homolog of the p21 class of Cyclin E/Cdk2
inhibitors, suggesting that a novel inhibitor is involved.
MATERIALS AND METHODS
Western Analysis and Antibody Stainings
To generate DmcycEII antisera, an N-terminal DmcycEII-GST
fusion protein was generated by insertion of the region encoding
the unique 119 amino acids of DmcycEII as a BamHI fragment,
generated by the polymerase chain reaction (PCR) using Pfu poly-
merase (Stratagene) from pT3T718U-DmcycEII, into pGEX-30X
(Amersham Pharmacia Biotech). PCR primers were: 59, 59-CGG
GAT CCT TAT GGG TTT AAA TGC CAA GAG-39; and 39,
59-CGG GAT CCC GTT TGA ATC GCT GCT TAA ACG-39.
SDS–polyacrylamide gel-purified DmcycEII N-terminal-GST fu-
sion protein was used to inoculate rats and, following two boosts,
the sera were harvested. The DmcycE rat antibody was generated
by using the full-length DmcycEI protein produced from the T7
inducible plasmid pRK171-DmcycEI (Richardson et al., 1995) as
described above.
For Western analysis of DmcycE proteins, Drosophila larval
protein extracts were prepared by homogenization of 3 larvae or
from dissected eye-antennal discs from 20 larvae in protein load
buffer (as described by Secombe et al., 1998). DmcycE was detected
by using anti-DmcycEII or anti-DmcycE polyclonal serum (raised
in rats) or the 8B10 mouse anti-DmcycE monoclonal serum (Rich-
ardson et al., 1995). Secondary antibodies conjugated to horseradish
peroxidase (HRP) were used and detection was by enhanced chemi-
luminescence (Amersham Inc.).
To examine the distribution of DmcycE proteins in Drosophila
embryos and larval tissues, samples were fixed in 4% formalde-
hyde, incubated with rat polyclonal DmcycEII, mouse polyclonal,
8B10 monoclonal, or rat polyclonal DmcycE antibodies, followed
by biotinylated secondary antibody, as described in Richardson et
© 2001 Elsevier Science. Aal. (1995). Detection was by Vectastain streptavidin-HRP (Vector
Labs.) and HRP staining. Costaining with DmcycE and Dacapo
in eye discs was carried out by using rat polyclonal DmcycE
antisera and with an anti-Dacapo monoclonal antibody (ob-
tained from I. Hariharan). Secondary antibodies were anti-
rat-biotin and streptavidin-Alexa 488 (Molecular Probes) and
anti-mouse-Texas Red. To detect the expression of Dacapo
relative to the MF, the MF was visualized by using dpp-LacZ
transgenic flies (obtained from W. Gelbart), by costaining with
anti-LacZ and anti-Dap antibodies. LacZ was detected by using a
rabbit anti-LacZ antibody followed by SA-rhodamine. All sec-
ondary antibodies were from Jackson ImmunoResearch Labs.,
unless otherwise stated.
Construction of DmcycE Transgenic Flies
To obtain DmcycEII under control of the hsp70 heat shock
promoter, a BamHI fragment containing the DmcycEII coding
region was generated by PCR using Pfu polymerase and NB23 DNA
(DmcycEII in pNB40) and cloned into pCaSpeR-hs, as previously
described for DmcycEI (Richardson et al., 1993). PCR primers were:
59, 59-CGG GAT CCT TAT GGG TTT AAA TGC CAA GAG-39;
and 39, 59-CGG GAT CCA CTT AAC GTA GAC TG-39. To obtain
the 195DN, 519DC, and 195DN519DC truncated forms of DmcycE,
PCR was carried out by using Taq polymerase (Perkin Elmer-Cetus)
or UlTma Polymerase (Perkin Elmer Applied Biosystems) and the
E41–3 DmcycEI cDNA clone (in pT7T319U; Richardson et al.,
1993) as template. The following primers were used in combination
with the reverse and T3 vector primers; 59, 59-GGA ATT CAA GAT
GCC GAC GCC CAT GTC G-39; and 39, 59-GGA ATT CTA AGC
CAT AAG CAC TTC GTC-39. PCR products were cloned into
pBluescript and those generated by using Taq Polymerase were
sequenced before cloning into pCaSpeR-hs. For construction of
12DN-DmcycEI, PCR was carried out by using ELONGase enzyme
mix (Gibco BRL) and E41–3 DNA. Primers were: 59, 59-CGG GAT
CCA AAA TGG ACC CTG AAC TCG G-39; and 39, 59-CGG GAT
CCT CAG GGA TTG CTT CTA C-39. PCR products were cloned
into pBluescript and the sequence determined before cloning into
pCaSpeR-hs.
Transgenic flies containing these constructs were obtained by P
element-mediated germline transformation. The following ho-
mozygous transgenic stocks were used: hsp70-DmcycEII on the X
chromosome (Z4), hsp70-D195N-DmcycEI (1.2), hsp70-D519C-
DmcycEI (C1) and hsp70-D195ND519C-DmcycEI (B3) on the 2nd
chromosome, hsp70-D12N-DmcycEI (H23A) on the 3rd chromo-
some, and hsp70-DmcycEI on the 3rd chromosome (Richardson et
al., 1995).
Induction of hsp70-DmcycE Expression and BrdU
Labeling
Heat shock induction of DmcycE in wandering third instar
larvae was carried out at 37°C for 1 h, followed by recovery at 25°C
or 18°C before dissection. BrdU labeling was carried out as described
by Secombe et al. (1998). To analyze S phase induction by hsp70-
DmcycEI in a dacapo mutant background, dacapo4454/GlaBc;
hsp70-DmcycEI flies were crossed to dacapo2X10/GlaBc. Homozy-
gous dacapo mutant larvae were picked by the absence of the Bc
(Blackcell) marker, heat shocked, and recovered for 2 h before BrdU
labeling.
ll rights reserved.
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For yeast two-hybrid analysis, a DmcycEI N terminal-LexA
fusion protein was generated by insertion of the region encoding
the first 46 amino acids of DmcycEI, generated by PCR as a BamHI
fragment, into pEG202 (Gyuris et al., 1993). PCR primers were: 59,
59-CGG GAT CCT TAT GAA GTT GGA AC-39; and 39, 59-CGG
GAT CCG AGG AGG CAA CCG ATG ACA GAT TG-39. A
DmcycEI C-terminal-LexA fusion protein was generated by inser-
tion of the region encoding the last 86 amino acids of DmcycE,
generated by PCR using Pfu polymerase and cloned as a BamHI
fragment into pEG202 (Gyuris et al., 1993). PCR primers were: 59,
59-CGG GAT CCT TAT GGC TCA GGA TG-39; and 39, 59-CGG
GAT CCT CAG GGA TTG CTT CTA C-39. Full-length DmcycEI
and II were cloned into pGilda (Origene Technologies) from
pRF-DmcycEI and pRF-DmcycEII (obtained from R. Finley).
EGY48 yeast cells containing DmcycE constructs and Dacapo (cki4
in pJG4–5; Finley and Brent, 1994, 1995) were analyzed for their
ability to induce expression of the chromosomal LEU2 reporter and
lacZ from the reporter plasmid, pSH18–34 (Gyuris et al., 1993;
Finley and Brent, 1994). lacZ expression was analyzed by using 40
mg/ml of 5-bromo-4-chloro-3-indolyl-b-D-thiogalactoside (X-gal).
For DmcycE/Cdk2 inhibition analysis in yeast, the following
yeast strains were generated: DmcycEI#70; pGAL-DmcycEI ADE1,
pGAL-cdk2 and DmcycEII#22; pGAL-DmcycEII ADE1, pGAL-
cdk2. DmcycEI or DmcycEII were cloned as PCR-generated frag-
ments containing BamHI sites (using primers described above) into
the BamHI site of pGAL ADE1, constructed from YCpG2 (Rich-
ardson et al., 1993) by replacement of the URA3 and LEU2 genes by
ADE1 using the EcoRI and SmaI sites. Plasmids were transformed
into the yeast strain 15D ura3 leu2 his2 ade1 trp1 containing Dm
cdk2 under control of the pGAL promoter (constructed from
YCpG2 Dm cdk2; Lehner and O’Farrell, 1989) integrated into the
his2 gene. Coexpression of DmcycE and Cdk2 was achieved by
growth on galactose media. Yeast transformation was carried out as
previously described (Richardson et al., 1993).
Assay for b-Galactosidase in Liquid Cultures
Yeast were diluted from an overnight culture, into selective
media to an ODA600 of 0.5, and allowed to grow for 5 h at 30°C with
shaking. The cells were pelleted and resuspended in 4 ml Z buffer
(60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
0.27% b-mercaptoethanol, pH 7.0). The ODA600 was determined
and reactions set up with 0.5 ml sample and 0.5 ml Z buffer. Cells
were lysed by adding SDS and chloroform and LacZ activity was
assayed after addition of 0.2 ml of 4 mg/ml o-Nitrophenyl-D-
galactopyranoside (ONPG), at 30°C. The reaction was terminated
by addition of 0.4 ml of 1 M Sodium Carbonate, cell debris was
pelleted, and ODA420 was measured. LacZ units 5 1000 3 OD420/
[time (min) 3 vol (ml) 3 OD600].
Microscopy
Embryo and larval samples were mounted on slides in 80%
glycerol and photographed by using a cooled CCD camera on a
Ziess Axiophot microscope with Nomarski optics. For Confocal
analysis, a Biorad MRC1000 Confocal microscope was used.
© 2001 Elsevier Science. ARESULTS
Distribution of Drosophila Cyclin EI and EII
Proteins during Development
To investigate the distribution of DmcycE protein during
embryogenesis, we used DmcycE polyclonal antisera raised
to the region of DmcycE present in both of the Cyclin E
proteins (Richardson et al., 1995). During the first 16
embryonic cell cycles, maternal DmcycEII protein (preva-
lent during 0–3 h AED; see Fig. 2) and zygotic DmcycEI
protein (prevalent after 3 h AED) are nuclear localized in
interphase cells (Figs. 1A–1F). At the onset of prophase,
DmcycE becomes dispersed throughout the cytoplasm until
late in telophase, where again it becomes localized to the
nucleus (Figs. 1A–1F). Although less DmcycE protein ap-
pears to be present in mitotic cells, this is due to dispersion
or epitope masking rather than degradation since analysis
by immunoblotting has shown that DmcycE protein levels
do not decrease during mitosis (Sauer et al., 1995).
Throughout embryogenesis, DmcycE protein is present
in proliferating cells but is down-regulated as cells stop
dividing. After the 16th mitosis, most cells in the embryo
enter their first G1 phase and begin to differentiate. At this
time, DmcycE is no longer detected in differentiating epi-
dermal cells but is present in patches of epidermal cells in
the thoracic segments (Fig. 1G), which go through one
further cycle (Knoblich et al., 1994). When proliferation of
cells in the thoracic patches ceases, DmcycE is no longer
detected in these cells (Fig. 1H) but is still present in the
dividing cells of the central and peripheral nervous system
(Figs. 1G–1L). As the nervous system cells cease division,
expression of DmcycE protein also ceases. This is evident in
peripheral nervous system cells, where DmcycE protein is
no longer present when these cells cease proliferation
(compare Fig. 1I with Figs. 1K and 1L). In addition, DmcycE
protein can be detected at low levels in endoreplicating
tissues when S phases are occurring (Figs. 1J and 1L; and
data not shown). Thus, the pattern of DmcycE protein
distribution during embryogenesis generally correlates with
the pattern of DmcycE mRNA (Richardson et al., 1993;
Knoblich et al., 1994), being expressed in mitotically pro-
liferating and endoreplicating cells and down-regulated
when these cells cease replication.
To specifically investigate the localization and distribu-
tion of the DmcycEII protein during development, an anti-
body was raised in rats to the unique N-terminal 119 amino
acids of the DmcycEII protein. Western analysis of Dro-
sophila larval extracts showed that the antisera detected
protein bands at ;80 kDa after heat shock induction of a
heat shock-inducible DmcycEII transgene. No bands were
detected in extracts from larvae after expression of a heat
shock-inducible DmcycEI transgene (Fig. 2A), demonstrat-
ing that the antibody is specific for the DmcycEII protein.
To investigate the tissue distribution of DmcycEII pro-
tein during embryonic development, DmcycE antibody
stainings were carried out. In early embryos, DmcycEII
ll rights reserved.
FI
G
.3
.
E
ct
op
ic
ex
pr
es
si
on
of
D
m
cy
cE
II
dr
iv
es
al
l
ce
ll
s
w
it
h
in
th
e
m
or
ph
og
en
et
ic
fu
rr
ow
in
to
S
ph
as
e.
(A
)S
ch
em
at
ic
re
pr
es
en
ta
ti
on
of
ce
ll
cy
cl
e
pr
og
re
ss
io
n
in
th
e
ey
e
im
ag
in
al
di
sc
.I
n
th
e
an
te
ri
or
re
gi
on
(A
),
ce
ll
s
ar
e
di
vi
di
n
g
as
yn
ch
ro
n
ou
sl
y,
w
it
h
ce
ll
s
in
al
l
ph
as
es
of
th
e
ce
ll
cy
cl
e.
A
s
th
e
w
av
e
of
di
ff
er
en
ti
at
io
n
,m
ar
k
ed
by
an
in
de
n
ta
ti
on
re
fe
rr
ed
to
as
th
e
m
or
ph
og
en
et
ic
fu
rr
ow
(M
F)
,p
ro
ce
ed
s
an
te
ri
or
ly
,c
el
ls
be
co
m
e
sy
n
ch
ro
n
iz
ed
in
G
1
ph
as
e.
Im
m
ed
ia
te
ly
po
st
er
io
r
(P
)t
o
th
e
M
F,
a
su
bs
et
of
ce
ll
s
en
te
r
a
sy
n
ch
ro
n
ou
s
S
ph
as
e
fo
ll
ow
ed
by
m
it
os
is
.(
B
–D
)S
ph
as
es
,d
et
ec
te
d
by
B
rd
U
la
be
li
n
g,
2
h
fo
ll
ow
in
g
h
ea
t
sh
oc
k
in
du
ct
io
n
of
D
m
cy
cE
tr
an
sg
en
es
.(
B
)C
on
tr
ol
h
ea
t-
sh
oc
k
ed
ey
e
di
sc
.(
C
)h
sp
70
-D
m
cy
cE
II
ey
e
di
sc
sh
ow
in
g
th
at
al
l
ce
ll
s
w
it
h
in
th
e
M
F
ar
e
dr
iv
en
in
to
S
ph
as
e.
(D
)h
sp
70
-D
m
cy
cE
I
ey
e
di
sc
sh
ow
in
g
an
in
cr
ea
se
in
S
ph
as
e
ce
ll
s
in
th
e
an
te
ri
or
pa
rt
of
th
e
M
F
an
d
in
ce
ll
s
im
m
ed
ia
te
ly
po
st
er
io
r
to
th
e
M
F.
(E
)h
sp
70
-D
m
cy
cE
I
ey
e
di
sc
at
18
0
m
in
af
te
r
h
ea
t
sh
oc
k
in
du
ct
io
n
st
il
l
sh
ow
in
g
an
ab
se
n
ce
of
S
ph
as
es
w
it
h
in
th
e
po
st
er
io
r
pa
rt
of
th
e
M
F.
(F
–H
)D
m
cy
cE
an
ti
bo
dy
st
ai
n
in
g
of
ey
e
di
sc
s
of
w
il
d
ty
pe
(F
),
h
sp
70
-D
m
cy
cE
II
(G
),
an
d
h
sp
70
-D
m
cy
cE
I
(H
)a
t
2
h
fo
ll
ow
in
g
h
ea
t
sh
oc
k
in
du
ct
io
n
of
D
m
cy
cE
tr
an
sg
en
es
.E
ye
di
sc
s
ar
e
or
ie
n
ta
te
d
an
te
ri
or
to
th
e
ri
gh
t
an
d
th
e
M
F
is
in
di
ca
te
d
by
th
e
ba
r
in
th
is
an
d
al
l
su
bs
eq
u
en
t
fi
gu
re
s.
(I
)W
es
te
rn
an
al
ys
is
of
D
m
cy
cE
pr
ot
ei
n
le
ve
ls
in
la
rv
ae
at
2
h
af
te
r
h
ea
t
sh
oc
k
in
du
ct
io
n
of
D
m
cy
cE
tr
an
sg
en
es
u
si
n
g
th
e
D
m
cy
cE
8B
10
m
on
oc
lo
n
al
an
ti
se
ra
.
A
t
th
is
ex
po
su
re
,
th
e
en
do
ge
n
eo
u
s
D
m
cy
cE
pr
ot
ei
n
ba
n
ds
ar
e
n
ot
pr
es
en
t
in
th
e
h
ea
t
sh
oc
k
ed
w
il
d-
ty
pe
co
n
tr
ol
tr
ac
k
.
162 Crack et al.© 2001 Elsevier Science. All rights reserved.
163S Phase Induction by Drosophila Cyclin EI and IIprotein was detected at high levels in interphase nuclei but
upon entry into mitosis became distributed throughout the
cytoplasm (Fig. 2B; and data not shown). In cellularized
cycle 14 embryos, DmcycEII was also detected at high
levels in the nuclei of interphase cells (Fig. 2C). However, at
later developmental times in embryos undergoing cycles 15
and 16, low levels of the DmcycEII protein were detected
throughout most of the embryo, although higher levels
were present in the amnioserosa (Fig. 2D; and data not
shown). At slightly later times (stage 13) when most epider-
mal cells have arrested in G1, DmcycEII protein was unde-
tectable in the epidermis or in proliferating cells of the
central and peripheral nervous system (Figs. 2E and 2F). The
persistence of DmcycEII protein during cycles 15 and 16 is
consistent with the observation that DmcycE zygotic null
mutants complete cycles 15 and 16 and arrest in G1 in cycle
17 (Knoblich et al., 1994). In addition, DmcycEII protein
persisted in the pole cells until late in embryogenesis (Figs.
2E and 2F), consistent with the presence of the DmcycEII
transcript in these cells (Richardson et al., 1993).
We also examined the distribution of DmcycEII in larval
tissues by Western analysis, using the anti-DmcycEII anti-
body. Third instar larval eye-antennal discs and wing discs
contained DmcycEII protein (data not shown). However, we
have been unable to determine the specific localization of
DmcycEII in these tissues by antibody staining, due to
background problems. DmcycEII has also been detected in
wing discs in the study of Prober and Edgar (2000) and in the
nurse cells of ovaries (de Nooij et al., 2000).
DmcycEII, but Not DmcycEI, Can Drive All G1
Cells within the Morphogenetic Furrow
in Eye Imaginal Discs into S Phase
The Drosophila third instar larval eye imaginal disc is an
excellent tissue to examine developmental regulation of the
cell cycle. Cells arrest in G1 within and anterior to the
morphogenetic furrow (MF) prior to differentiation (see Fig.
3A; Thomas et al., 1994). For simplicity, we are defining the
MF to include all of these G1-arrested cells. Posterior to the
MF, a subset of cells enter S phase while the remainder
differentiate into photoreceptor cells. We have previously
shown that heat shock-induced ectopic expression of Dm-
cycEI can drive G1-arrested cells within the eye disc into S
phase, but cells within the posterior part of the MF are
refractory to ectopic expression of DmcycEI (Richardson et
al., 1995). To determine the relative ability of DmcycEII
and DmcycEI to induce G1-arrested cells in the eye disc into
S phase, we examined S phases by bromo-deoxyuridine
(BrdU) labeling after heat shock-induced expression of
hsp70-DmcycEII or hsp70-DmcycEI in transgenic larvae.
At 2 h after heat shock, DmcycEI induced G1-arrested cells
in the anterior part of the MF and cells in the post-MF S
phase region into S phase, but cells in the posterior part of
the MF remained arrested in G1 (Fig. 3D compared with Fig.
3B; and data not shown). A similar result was observed for
DmcycEII 1 h after heat shock-induced ectopic expression
© 2001 Elsevier Science. A(data not shown), indicating that DmcycEII can function in
the eye disc to induce G1-arrested cells into S phase.
However, at 2 h after induction, DmcycEII was able to
induce all of the G1-arrested cells within the MF into S
phase, including those in the posterior part of the MF that
are refractory to DmcycEI (Fig. 3C). Even after 3 h or longer
recovery times, DmcycEI was unable to induce cells in the
posterior part of the MF into S phase; indeed there were
generally less S phase cells than the control, possibly due to
the block to rereplication (Fig. 3E; and data not shown). The
increased potency of DmcycEII versus DmcycEI is not due
to differences in induction or localization of these proteins,
since Western analysis and immunostaining using antisera
that recognize both isoforms of DmcycE showed that simi-
lar amounts of proteins were induced and were present at
2 h after heat shock (Figs. 2A and 3F–3I). This effect was
time-dependent, since at 1 h after heat shock induction,
ectopic S phases were only observed in the anterior region
of the MF in both heat shock-induced DmcycEII and Dm-
cycEI eye discs (data not shown). These data suggest that
cells in the posterior region of the MF are more resistant
than anterior MF cells to being driven into S phase by
DmcycE, and that DmcycEII is more potent than DmcycEI
in overcoming this resistance.
The N-Terminal Region Prevents DmcycEI from
Inducing Posterior MF Cells into S Phase
One possible reason for the ability of DmcycEII but
not DmcycEI to drive posterior MF cells into S phase is
that DmcycEI contains an inhibitory domain that is
either not present or inactivated in DmcycEII. To inves-
tigate this, we first generated transgenic flies carrying
heat shock-inducible N-terminal (D195N-DmcycEI),
C-terminal (D519C-DmcycEI), or both N- and C-terminal
(D195ND519C-DmcycEI) truncations of DmcycEI (Fig. 4).
BrdU labeling of S phase cells was carried out after heat
shock induction of the transgenes in third instar larvae,
to determine whether these truncated versions of Dmcy-
cEI were capable of inducing ectopic S phases in larval
eye discs (Fig. 5). All truncated versions of DmcycEI were
able to drive G1 phase eye disc cells into S phase after
heat shock induction (Fig. 5), showing that the region
196 –518 amino acids spanning the cyclin box is suffi-
cient for ectopically expressed DmcycEI to drive G1 cells
into S phase. Furthermore, since the N-terminal deletion
removes the putative bipartite NLS, it appears that this
sequence is not essential for DmcycEI function (see
below).
Ectopic expression of D519C-DmcycEI, like full-length
DmcycEI, was only able to drive the anterior G1-arrested
MF cells into S phase (Figs. 5B and 3D). In contrast, both
truncations removing the 195 N-terminal region resulted in
ectopic S phases in all G1-arrested cells 2 h after heat shock
induction (Figs. 5A and 5C). We were unable to confirm that
this effect was not a result of higher levels of D195N-
DmcycEI or D195ND519C-DmcycEI relative to D519C-
ll rights reserved.
164 Crack et al.DmcycEI or full-length DmcycEI, since our antisera did not
recognize D195N-DmcycEI, although induced DmcycEII
and DmcycEI were present at similar levels (Fig. 3I).
Since DmcycEII and DmcycEI truncations that lack the
N terminus can induce posterior G1-phase MF cells into S
phase, we hypothesized that the unique N terminal 12
amino acids of DmcycEI contains a domain that responds to
an inhibitor in the posterior region of the MF. To test this,
we generated transgenic flies containing DmcycEI with a
specific deletion of the first 12 amino acids. Heat shock
expression of D12N-DmcycEI, resulted in induction of all
cells within the MF into S phase (Fig. 5D). Western analysis
showed that equivalent amounts of D12N-DmcycEI and
DmcycEI were present at 2 h following heat-shock induc-
tion, showing that this effect was not a result of more
D12N-DmcycEI protein being present at this time (Fig. 5E).
Staining of eye discs also revealed that there were similar
amounts of D12N-DmcycEI and DmcycEI proteins pro-
duced throughout the eye disc, including the MF, after heat
shock induction (Figs. 5F–5K). Interestingly D12N-DmcycEI
protein, unlike DmcycEI, was not specifically nuclear lo-
calized but rather was present in both cytoplasmic and
nuclear compartments (Figs. 5I–5K). This was more clearly
observed in the large salivary gland cells after heat shock-
induced expression of DmcycEI or D12N-DmcycEI (Figs.
5L–5Q). The deletion of the N-terminal 12 amino acids of
DmcycEI is expected to remove part of the potential bipar-
tite NLS QKRKF(X13)AKRQQR at amino acid positions
5–28. The loss of specific nuclear localization of D12N-
DmcycEI suggests that this putative NLS is a nuclear
targeting signal, although another less efficient mechanism
must exist to allow some nuclear localization of D12N-
DmcycEI. Furthermore, the fact that D12N-DmcycEI and
the larger N-terminal deletion constructs are able to effec-
tively trigger S phase suggests that DmcycEI is able to
function, when overexpressed at least, regardless of specific
targeting to the nucleus.
Dacapo Is Not the DmcycEI-Specific Inhibitor
A possible candidate for an inhibitor of DmcycE/Cdk2
activity in the posterior region of the MF in the eye disc is
the Drosophila homolog of the p21 Cdk inhibitor Dacapo,
which inhibits DmcycE/Cdk2 (de Nooij et al., 1996; Lane et
al., 1996). Dacapo is expressed in the posterior region of the
eye disc (de Nooij et al., 1996, 2000). To more precisely
define where Dacapo is expressed relative to the MF, eye
discs were costained for Dacapo and DmcycE (present in a
band of cells posterior to the MF; Richardson et al., 1995).
Dacapo expression overlapped with DmcycE-expressing
cells posterior to the MF but was not detectable anterior to
this within the MF (Figs. 6A–6C). Furthermore, costain-
ing with Dacapo and LacZ (expressed within the MF) in
eye discs from dpp-lacZ transgenic flies, showed that
Dacapo was present posterior to the strongly stained LacZ-
expressing cells (Figs. 6D–6F). Since Dacapo is not readily
detectable within the posterior part of the MF and given the
© 2001 Elsevier Science. Ahigh level of DmcycEI produced by heat-shock induction, it
is unlikely that Dacapo is the inhibitor that acts upon the
N-terminal region of DmcycEI in the posterior part of the
MF.
To further investigate the inhibition of DmcycEI and
DmcycEII by Dacapo, we carried out interaction studies in
yeast. Dacapo has been shown to bind to residues 193–517
of DmcycEI containing the cyclin box (Thomas et al., 1997);
however, it is possible that the different N-terminal regions
of DmcycEI and DmcycEII may influence this binding. In
yeast two-hybrid tests, Dacapo showed no significant inter-
action with the N-terminal 46 amino acids of DmcycEI, nor
the C-terminal region compared with the positive control
(Fig. 7A; Table 1). Also in yeast two-hybrid tests, Dacapo
did not show a stronger interaction with DmcycEI relative
to DmcycEII (Figs. 7B and 7C; Table 1). Furthermore, we
tested the ability of Dacapo to inhibit DmcycEI/Dm Cdk2
and DmcycEII/Dm Cdk2 using a functional assay in yeast.
Coexpression of DmcycE and Dm Cdk2 in yeast is lethal
(Fig. 7D). Dacapo rescued the lethality of DmcycEI/Dm
Cdk2 and DmcycEII/Dm Cdk2 expressing yeast equally
(Fig. 7D). Taken together, these data show that there is no
apparent difference in the ability of Dacapo to inhibit
DmcycEI/Dm Cdk2 relative to DmcycEII/Dm Cdk2.
Finally, to explore the role of Dacapo in restricting
DmcycEI function in vivo, we reduced the dose of Dacapo
in eye discs by the allelic combination of dacapo2X10/
dacapo4454 and ectopically expressed DmcycEI using hsp70-
DmcycEI. Ectopic expression of DmcycEI in the dacapo
mutant resulted in a dramatic increase in S phase cells in
eye discs at 2 h but was still unable to induce cells in the
posterior region of the MF into S phase (Fig. 7E). These data,
together with the results above, strongly suggest that Da-
capo does not specifically inhibit DmcycEI in the posterior
region of the MF.
DISCUSSION
Cyclin E Protein Distribution during Development
This study has compared the properties and distribution
of Drosophila Cyclin EI and II through development. Both
proteins are nuclear localized as is human Cyclin E (Oht-
subo et al., 1995) but become distributed in the cytoplasm
during mitosis. DmcycEII protein, which is maternally
deposited, is most abundant during early embryogenesis
while DmcycEI protein is present during later stages of
development.
The distribution of DmcycE protein during development
correlates with proliferating cells with a few exceptions.
DmcycE mRNA and protein are undetectable in all cases
but one (see below) in which cells are known to be in G1
phase. DmcycE protein is down-regulated in embryonic
epidermal cells when cells exit into G1 of cycle 17 and in
neural cells as they cease proliferation. Likewise, DmcycE
protein abundance in endoreplicating tissues correlates
with their known replication pattern. Furthermore, during
ll rights reserved.
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ment, DmcycE expression is absent in G1-arrested cells
(Richardson et al., 1995). In all of these cases, down-
regulation of DmcycE may be important in limiting cell
proliferation. The one known exception is the zone of
nonproliferating cells of the third instar larval wing disc,
which transiently arrest proliferation (Johnston and Edgar,
1998). In this tissue, DmcycE and the S phase transcription
factor E2F are present but inactive, suggesting that they
may be regulated by inhibitors such as Ckis or Retinoblas-
toma (de Nooij et al., 1996; Lane et al., 1996; Du et al.,
1996).
There are three other cases in which DmcycE is not
down-regulated in cells that have ceased proliferating. In
two cases, cells are arrested in G2 phase, where they may be
refractory to S phase induction by DmcycE. First, the
amnioserosa cells, which exit from the cell cycle in G2
phase of cycle 14, maintain high levels of DmcycE for at
least 1–2 h after they cease division. DmcycE in the
amnioserosa persists without the presence of detectable
DmcycE transcript (Richardson et al., 1993), implying that
DmcycE protein is stabilized in these cells. Second, in the
nonproliferating G2-arrested pole cells, DmcycE is also
maintained at high levels throughout embryogenesis even
though these cells remain dormant for at least 14 h and do
not recommence division until the end of embryogenesis
(Su et al., 1998). The presence of high levels of DmcycE
FIG. 4. DmcycE deletion constructs. (A) Schematic diagram of
DmcycEI and DmcycEII proteins and DmcycEI truncations. The
unique regions of DmcycEI and DmcycEII are shown by the
different patterned N-terminal regions, and the cyclin box present
in the central region is represented by the shaded box. Arrows
indicate the position of potential nuclear localization sequences
and the bar corresponds to the region containing the destabilizing
motif at position 542. Note that there is an alteration to the
published DmcycE sequence (ALPP at position 535 has been
changed to ALRAP) leading to an increase in size by one residue.protein in the pole cells correlates with high levels of
© 2001 Elsevier Science. Amaternally derived transcript localized to these cells during
early embryogenesis. This represents maternally derived
DmcycEII protein, since it is present in DmcycE-deficient
embryos that have no zygotic expression of DmcycE (Rich-
ardson et al., 1993, 1995) and is detected with the
DmcycEII-specific antibody (this study). For the same rea-
sons, DmcycE protein persisting in the amnioserosa is
likely to be mostly DmcycEII (Richardson et al., 1995; this
study). Third, as we have previously documented (Richard-
son et al., 1995), DmcycE is present in nonproliferating
cells in the lamina of third instar larval optic lobes but it is
not known at which cell cycle stage these cells are arrested.
Functional Domains of DmcycE
In this study, we have presented the first in vivo deletion
analysis of Cyclin E. We show that a 322-amino acid region
spanning the cyclin box (residues 196–518) is sufficient for
ectopic DmcycE function, that the potential bipartite NLS
of DmcycEI is important for nuclear localization, and that
the N terminal region of DmcycEI contains an inhibitory
domain.
Our results, defining the functional region of DmcycEI to
196–518 amino acids, are consistent with studies of human
Cyclin A. Deletion of the N-terminal 172 amino acids of
Cyclin A (corresponding to the N-terminal 216 amino acids
of DmcycE) had no effect on Cdk binding or activation
compared with full-length Cyclin A (Lees and Harlow,
1993; Jeffrey et al., 1995). The largest deletion of the C
terminus of human Cyclin A that still retained some
function, although considerably reduced, was to position
369 (Lees and Harlow, 1993), corresponding to position 433
of DmcycE. Furthermore, truncations of the N terminus of
human Cyclin E, which presumably initiated at methionine
129 (corresponding to residue 254 of DmcycE), were func-
tional in yeast (Lew et al., 1991).
The fact that deletions of the N-terminal regions of
DmcycEI containing the potential bipartite NLS at amino
acid positions 5–28 of DmcycEI were still functional raises
questions regarding the nuclear targeting of DmcycEI.
While full-length DmcycEI is nuclear-localized, we showed
that the D12N-DmcycEI was not specifically targeted to the
nucleus although some nuclear localization was evident.
This suggests that this putative NLS is likely to be mostly
responsible for the nuclear targeting of DmcycEI. The weak
nuclear staining observed for D12N-DmcycEI may be due to
the remaining part of the bipartite NLS, but this is unlikely
since a 40-amino acid N-terminal deletion completely re-
moving the NLS also shows some nuclear localization
(D.C., D. Coates, M.C., R.S., and H.R., unpublished data).
Nuclear localization may occur by the action of a novel
NLS or by association with another protein that becomes
nuclear localized. Interestingly, the N-terminal-deleted
DmcycEI proteins were apparently as functional as the
nuclear localized full-length DmcycEI and DmcycEII pro-
teins in inducing G1 cells into S phase. Since nuclear
localization of DmcycE is expected to be required for
ll rights reserved.
166 Crack et al.function, the fact that relatively low levels of nuclear-
localized D12N-DmcycEI is able to effectively induce S
phase entry suggests that these low levels of DmcycE are
sufficient for S phase induction or that D12N-DmcycEI is a
more potent S phase inducer than DmcycEI or DmcycEII.
The Function of DmcycEI and DmcycEII during
Development
An important developmental question is whether the two
FIG. 5. D195N-DmcycEI, D195ND519C-DmcycEI, and D12N-Dm
the eye disc into S phase (A–D). (A) hsp70-D195N-DmcycEI, (B) h
hsp70-D12N-DmcycEI third instar larvae were heat shocked for 1 h
showing the relative abundance of D12N-DmcycEI and DmcycEI p
induction. (F–Q) Anti-DmcycE (red) and Hoechst 33258 (blue) sta
DmcycEI (F–H) or D12N-DmcycEI (I–K) or in third instar larv
D12N-DmcycEI (O–Q). (F–H) DmcycEI in eye disc cells. (F) DmcycE
(J) DNA, (K) Merge. (L–N) DmcycEI in salivary glands. (L) Dmcyc
DmcycE, (P) DNA, (Q) Merge.isoforms of DmcycE, which are present at different devel-
© 2001 Elsevier Science. Aopmental stages, have different functions? In this study, we
have shown that heat shock-induced expression of Dmcy-
cEII was able to induce G1-arrested cells within the poste-
rior part of the MF into S phase, whereas DmcycEI could
not. Likewise, DmcycEI constructs lacking the unique 12
amino acids at the N terminus were able to induce all of the
G1-arrested cells within the MF into S phase. These results
suggest that the unique N-terminal region of DmcycEI acts
as an inhibitory domain. This inhibitory domain may be a
target for an inhibitor that is present within the posterior
, but not D519C-DmcycEI, can drive all G1 cells within the MF in
-D519C-DmcycEI, and (C) hsp70-D195ND519C-DmcycEI and (D)
llowed to recover for 2 h before BrdU labeling. (E) Western analysis
ns immediately (tracks 1, 3) and 2 h (tracks 2, 4) after heat shock
of eye disc cells spanning the MF after heat shock induction of
livary glands after heat shock induction of DmcycEI (L–N) or
NA, (H) Merge. (I–K) D12N-DmcycEI in eye disc cells. (I) DmcycE,
) DNA, (N) Merge. (O–Q) D12N-DmcycEI in salivary glands. (O)cycEI
sp70
and a
rotei
ining
al sa
, (G) D
E, (Mpart of the MF. Alternatively, the N-terminal region of
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167S Phase Induction by Drosophila Cyclin EI and IIDmcycEI may be an intrinsic inhibitory domain that re-
quires inactivation by the binding of an activator, which is
not present in the posterior part of the MF. It is intriguing
that the DmcycEII protein, which differs from DmcycEI
only by replacement of the 12 N-terminal amino acids of
DmcycEI with a novel 119-residue sequence, is able to
overcome inhibition in the posterior region of the MF. It
should be noted that BrdU labeling of these cells is not as
intense and that induction of these posterior MF cells into
S phase by DmcycEII occurs after S phase induction of the
anterior MF cells. This suggests that DmcycEII may be
partially sensitive to inhibition within the posterior region
of the MF. Interestingly, Drosophila Cyclin A appears to be
resistant to inhibition within the posterior region of the
MF, since ectopic expression of Cyclin A can induce all
cells within the MF into S phase with equal efficacy (Dong
et al., 1997).
FIG. 6. Dacapo localization relative to the MF in the eye disc. (A–C
(red), (B) Dacapo (green), and (C) Merge. (D–F) Antibody staining o
(E) Dacapo (blue), and (F) Merge.What is different about the posterior part of the MF? Our
© 2001 Elsevier Science. Aprevious studies have revealed differential regulation of G1
arrest in the anterior and posterior regions of the MF
(Horsfield et al., 1998). The Drosophila TGFb homolog,
decapentaplegic (dpp), is expressed in the G1-arrested cells
of the MF (Masucci et al., 1990) and is required to establish
G1 arrest in the anterior part of the MF (Penton et al., 1997;
Horsfield et al., 1998). In posterior MF cells, a Dpp-
independent mechanism mediates G1 arrest (Horsfield et
al., 1998). It is possible that the Dpp-independent mecha-
nism for G1 arrest in the posterior region of the MF is
related to the mechanism that we have observed in this
study that acts upon the N terminus of DmcycEI. If this
Dpp-independent mechanism occurs by the induction of an
inhibitor, it is unlikely that this inhibitor is Dacapo. The
results presented here show that Dacapo was not detectable
in the posterior part of the MF and did not show higher
binding efficiency or inhibition of DmcycEI/Dm Cdk2 com-
tibody staining of an eye disc for DmcycE and Dacapo. (A) DmcycE
eye disc from dpp-lacZ flies for LacZ and Dacapo. (D) LacZ (red),) An
f anpared with DmcycEII/Dm Cdk2. Nor was ectopic expression
ll rights reserved.
168 Crack et al.FIG. 7. Dacapo does not interact more strongly with DmcycEI than EII or play an important role in restricting S phases in the MF of the
eye disc. (A) Yeast two-hybrid analysis of pJG4–5-dacapo (pJG-Dap) with the pEG202-DmcycEI-46N (PEG-N) and pEG202-DmcycEI-C
(PEG-C) constructs in EGY48 containing the pSH18–34 LacZ reporter plasmid on galactose X-Gal 1 leucine plates. (B) Yeast two-hybrid
© 2001 Elsevier Science. All rights reserved.
169S Phase Induction by Drosophila Cyclin EI and IIof DmcycEI able to induce posterior MF cells into S phase in
dacapo mutant eye discs. Another Cdk inhibitor that func-
tions within the MF of the eye disc is Roughex (Rux), which
has been shown to inhibit Cyclin A/Cdk, but not Cyclin
EI/Cdk2, induction of S phase in embryos and eye imaginal
discs (Thomas et al., 1994, 1997). Rux functions by down-
regulating Cyclin A accumulation, while Cyclin E/Cdk2
binds to, phosphorylates, and down-regulates Rux (Thomas
et al., 1997). Furthermore, we showed that DmcycEI and
DmcycEII bound to Rux with equal affinity in yeast two-
hybrid assays (data not shown). Another mediator of G1
arrest, that can act downstream of Cyclin E function by
inhibiting the activity of the S phase transcription factors
E2F/DP, is the Retinoblastoma (Rb) protein (reviewed by
Dyson, 1998). The Drosophila Rb (Rbf1) is also unlikely to
be involved in this inhibition, since in rbf1 mutant eye
discs, although the anterior MF cells do not arrest in G1,
posterior MF cells remain G1-arrested (Du, 2000). Since
Dacapo, Rux, and Rbf1 are unlikely to mediate the inhibi-
tion of DmcycEI in the posterior part of the MF, the
mechanism of DmcycEI inhibition remains to be deter-
mined. We are currently carrying out a genetic screen for
mutants that can dominantly enhance the rough eye pheno-
type due to overexpression of DmcycEI, as well as a yeast
two-hybrid screen for proteins that can bind the N-terminal
region of DmcycEI, in order to identify such an inhibitor.
What is the function of DmcycEII during development?
DmcycEII has been detected in third instar larval eye and
wing imaginal discs (Prober and Edgar, 2000; this study).
Although we have been unable to determine the precise
cells in which DmcycEII is expressed in these tissues,
DmcycEII may play an important role in specific cells in
overcoming an inhibitor to drive entry into S phase. For
example, it is possible DmcycEII may be expressed in the
post-MF S phase region of the eye imaginal disc and be
specifically required here to overcome a G1-S phase inhibi-
tor that is expressed at high levels within the MF.
During embryogenesis, DmcycEII is present at high levels
in the early embryo where cell cycles are very rapid and
essentially have no G1 or G2 phases. It is possible that
DmcycEII has a role in allowing the very rapid S phases
to occur in these early embryonic cycles. The demonstra-
tion that ectopically expressed DmcycEII is largely resistant
to an inhibitor in the eye disc that targets DmcycEI,
suggests one way in which the specific properties of Dm-
cycEII may be promoting the rapid embryonic cycles. For
analysis of pJG4–5-dacapo (pJG-dap, top) or pJG4–5 (pJG, below) w
EGY48 containing the pSH18–34 LacZ reporter plasmid on galactos
pGilda-DmcycEI (EI) and pGilda-DmcycEII (EII) assayed on galacto
Blue-coloration on X-Gal 1 leucine plates or growth on galactose w
of the lethality of yeast expressing DmcycEI/Cdk2 and DmcycEII/
empty vector (pJG). Tenfold serial dilutions of yeast suspended from
or galactose plates. (E) Induction of S phases assayed by BrdU label
2 h after heat shock induction (dap hs-cycEI) compared with a heat sho
© 2001 Elsevier Science. Aexample a maternally supplied inhibitor may be unable to
effectively inhibit DmcycEII/Cdk2 function in vivo, allow-
ing for immediate entry into S phase after the completion of
mitosis in these early cycles. In contrast, once DmcycEI
protein starts to predominate after postblastoderm cycle 14
expression of the potential inhibitor may more readily
inhibit DmcycEI/Cdk2 function and lead to G1 arrest.
It is possible that similar mechanisms exist in mamma-
lian cells to allow different types of cell cycles to occur.
Interestingly, three different splice variants of human Cy-
clin E have been reported (Sewing et al., 1994; Ohtsubo et
al., 1995; Mumberg et al., 1997). Two of these variants, Es
and Et, are unable to activate Cdk2 activity, suggesting that
they may act in a dominant-negative manner in the G1 to S
phase transition (Sewing et al., 1994; Mumberg et al., 1997).
In contrast, protease cleaved N-terminal truncated forms
(deleting ;45 or ;69 N-terminal amino acids) of human
Cyclin E have been identified in tumor cells that have
higher activity and greater S phase-inducing potential than
full-length Cyclin E (Porter and Keyomarski, 2000; Porter et
al., 2001). These data suggest that human Cyclin E may also
be subjected to an inhibitory mechanism that acts at the
TABLE 1
Interaction of DmcycE with Dacapo
Interactors
LacZ activity
unitsa
Relative
increaseb
pEG-CycE-46N 1 Dap 0.71 6 0.59 13
pEG-CycE-46N 1 pJG 1.10 6 0.76
pEG-CycE-Cterm 1 Dap 0.57 6 0.53 13
pEG-CycE-Cterm 1 pJG 1.07 6 0.29
pGilda-DmEI 1 Dap 19.1 6 4.1 15.73
pGilda-DmEI 1 pJG 1.21 6 0.56
pGilda-DmEII 1 Dap 30.94 6 5.6 23.43
pGilda-DmEII 1 pJG 1.32 6 0.28
pAS-SNF1 1 pACT-SNF4c 71.79 6 5.4
a The yeast strain EGY48 containing the pSH18-34 LacZ reporter
plasmid transformed with the listed bait and prey plasmids was
grown in Galactose media then assayed for LacZ activity. LacZ
units were determined relative to the number of cells, using the
formula: U 5 1000 3 OD420/[time (min) 3 vol (ml) 3 OD600].
b Increase relative to basal level (pJG).
c Yeast two-hybrid-positive control.
pGilda-DmcycEI (pGilda-EI) and pGilda-DmcycEII (pGilda-EII) in
al 1 leucine plates. (C) pJG4–5-dacapo (pJG-dap) interaction with
lates without leucine, by spotting tenfold dilutions onto the plate.
ut leucine plates indicate protein–protein interactions. (D) Rescue
(by growth on galactose plates) by Dacapo (pJG-dap) but not the
gle colonies (3 colonies for each) were spotted vertically on glucose
eye discs from dacapo mutant hsp70-DmcycEI (1 copy) eyes discith
e X-G
se p
itho
Cdk2
sin
ing in
cked w1118 eye disc (control).
ll rights reserved.
170 Crack et al.N-terminal region. Furthermore, a second mammalian cy-
clin E cDNA, cyclin E2, that encodes a protein differing
significantly in its N-terminal region to Cyclin E1, has been
identified (Lauper et al., 1998; Zariwala et al., 1998; Gudas
et al., 1999). It will be interesting to determine whether
cyclin E2 and cyclin E1 are differentially expressed during
mouse development and whether Cyclin E2 is a more
potent inducer of S phase than Cyclin E1 or vice versa.
In summary, the results of this study have revealed the
existence of a novel inhibitory domain at the N terminus of
DmcycEI that prevents ectopic DmcycEI from inducing G1
cells within the posterior region of the MF into S phase.
Although DmcycE is normally not expressed at detectable
levels within the MF, it is possible that such a mechanism
prevents low levels of DmcycE protein from functioning
inappropriately during eye development. The results de-
scribed here have also demonstrated that DmcycEII is
largely resistant to the inhibitory mechanism that acts on
DmcycEI, highlighting the complexity of G1-S regulation
and exposing a novel cell cycle regulatory mechanism that
acts during development.
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